Atlantis Eyecare offers the most cutting-edge technology and advanced procedures available today. To continue as a leader in the latest eye care methods for patients, we closely work with some of the largest pharmaceutical and medical device organizations in the world. With 9 clinics, our department of research is well-equipped to be involved in a wide range of studies. Each of our renowned ophthalmologists at Atlantis Eyecare have dozens of studies to their names and our research team of certified technicians, optometrists, and coordinators use their vast experience to handle a variety of studies.
Studies we are currently involved in include:
Glaucoma and Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension.
Short-term Evaluation of Combination Corticosteroid + Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy (DRCR.net).
Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk (DRCR.net).
Multiple Clinical Trials in Advanced Next-Generation Treatments for Wet Macular Degeneration.
AMO Tecnis Toric Post-Approval Study (a research study to evaluate a post-marketed intraocular lens (IOL) for patients with cataracts).
We are also involved in studies for the latest in dry eye therapy and many new advanced technology IOLs and surgical devices.
Drs. Ehsan Sadri, Dwayne K. Logan, and Hani Salehi-Had have achieved a level of excellence in the field of research that few can match.